Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rick Kaplan"'
Autor:
Angela Meade, Elena Frangou, Babak Choodari-Oskooei, James Larkin, Tom Powles, Grant D. Stewart, Laurence Albiges, Axel Bex, Toni K. Choueiri, Ian D. Davis, Tim Eisen, Alison Fielding, Craig Gedye, David J. Harrison, Rick Kaplan, Salena Mulhere, Paul Nathan, Grisma Patel, Jay Patel, Hannah Plant, Alastair Ritchie, Hannah Rush, Clare Shakeshaft, Martin R. Stockler, Cristina Suarez, Jemima Thompson, Nat Thorogood, Balaji Venugopal, Mahesh K.B. Parmar
Publikováno v:
Contemporary Clinical Trials Communications, Vol 42, Iss , Pp 101381- (2024)
Clinical trials to establish the efficacy of new agents in the adjuvant cancer setting typically take many years to complete. During that time, external factors can impact recruitment and reporting plans. An example is a new standard of care becoming
Externí odkaz:
https://doaj.org/article/152a532dd63f4c618fd32817ead311e1
Autor:
Bhavna Oza, Tim Eisen, Eleni Frangou, Grant D. Stewart, Axel Bex, Alastair W.S. Ritchie, Rick Kaplan, Benjamin Smith, Ian D. Davis, Martin R. Stockler, Laurence Albiges, Bernard Escudier, James Larkin, Steven Joniau, Barry Hancock, Gregers G. Hermann, Joaquim Bellmunt, Mahesh K.B. Parmar, Patrick Royston, Angela Meade
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(16)
PURPOSE The 2003 Leibovich score guides prognostication and selection to adjuvant clinical trials for patients with locally advanced renal cell carcinoma (RCC) after nephrectomy. We provide a robust external validation of the 2003 Leibovich score usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3ef8539b32f9be056cd35e514d76e1f
https://pubmed.ncbi.nlm.nih.gov/35213214
https://pubmed.ncbi.nlm.nih.gov/35213214
Autor:
Ruth E, Farmer, Deborah, Ford, Rohini, Mathur, Nish, Chaturvedi, Rick, Kaplan, Liam, Smeeth, Krishnan, Bhaskaran
Publikováno v:
International Journal of Epidemiology
Background Previous studies provide conflicting evidence on whether metformin is protective against cancer. When studying time-varying exposure to metformin, covariates such as body mass index (BMI) and glycated haemoglobin (HbA1c) may act as both co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c7971d43258863d318e18e0db1cd8290
https://pubmed.ncbi.nlm.nih.gov/30753459
https://pubmed.ncbi.nlm.nih.gov/30753459